# SALIX PHARMACEUTICALS LTD — Form D

SALIX PHARMACEUTICALS LTD of Raleigh, NC, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-10. The offering totals $750.0M, of which $750.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-01-10
- Form: D
- Accession: 0001209191-14-002846
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $750.0M
- Amount sold: $750.0M
- Investors: 7
- Date of first sale: 2013-12-27
- Security types: debt
- Revenue range: Over $100,000,000
- SEC file number: 021-209813

## Issuer

- Name: SALIX PHARMACEUTICALS LTD
- CIK: 0001009356
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 8510 Colonnade Center Drive, Raleigh, NC, 27615
- Phone: 919-862-1000

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| John F Chappell | Director | Raleigh, NC |
| Thomas W D'Alonzo | Director | Raleigh, NC |
| William P Keane | Director | Raleigh, NC |
| Carolyn J Logan | Director | Raleigh, NC |
| Mark A Sirgo | Director | Raleigh, NC |
| Adam C Derbyshire | Executive Officer | Raleigh, NC |
| William P Forbes | Executive Officer | Garden City, NY |
| Carolyn J Logan | Executive Officer | Raleigh, NC |
| Rick D Scruggs | Executive Officer | TEL AVIV, L3 |

## More

- [CIK 1009356 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1009356&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001209191-14-002846.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.